Sio Gene Therapies Stock Total Debt
| SIOXDelisted Stock | USD 0.40 0.01 2.56% |
Sio Gene Therapies fundamentals help investors to digest information that contributes to Sio Gene's financial success or failures. It also enables traders to predict the movement of Sio Stock. The fundamental analysis module provides a way to measure Sio Gene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sio Gene stock.
Sio |
Sio Gene Therapies Company Total Debt Analysis
Sio Gene's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Sio Gene Total Debt | 2.36 M |
Most of Sio Gene's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sio Gene Therapies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Sio Gene Therapies has a Total Debt of 2.36 M. This is 99.91% lower than that of the Healthcare sector and 99.27% lower than that of the Biotechnology industry. The total debt for all United States stocks is 99.96% higher than that of the company.
Sio Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sio Gene's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sio Gene could also be used in its relative valuation, which is a method of valuing Sio Gene by comparing valuation metrics of similar companies.Sio Gene is currently under evaluation in total debt category among its peers.
Sio Fundamentals
| Return On Equity | -0.47 | |||
| Return On Asset | -0.24 | |||
| Current Valuation | (23.36 M) | |||
| Shares Outstanding | 73.98 M | |||
| Shares Owned By Insiders | 25.30 % | |||
| Shares Owned By Institutions | 26.82 % | |||
| Number Of Shares Shorted | 71.39 K | |||
| Price To Book | 0.54 X | |||
| EBITDA | (70.94 M) | |||
| Net Income | (71.89 M) | |||
| Cash And Equivalents | 54.77 M | |||
| Cash Per Share | 0.74 X | |||
| Total Debt | 2.36 M | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 6.46 X | |||
| Book Value Per Share | 0.61 X | |||
| Cash Flow From Operations | (60.35 M) | |||
| Short Ratio | 0.11 X | |||
| Earnings Per Share | (0.38) X | |||
| Target Price | 5.0 | |||
| Number Of Employees | 12 | |||
| Beta | 1.49 | |||
| Market Capitalization | 30.63 M | |||
| Total Asset | 75.08 M | |||
| Z Score | 7.2 | |||
| Net Asset | 75.08 M |
About Sio Gene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sio Gene Therapies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sio Gene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sio Gene Therapies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Sio Stock
If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |